Search clinical trials for: VRC-MALMAB0100-00-AB
Total 110 results
-
National Institute of Allergy and Infectious Diseases...National Institutes of Health (NIH); University of Washington; Malaria Research... and other collaboratorsCompleted
-
National Institute of Allergy and Infectious Diseases...University of Washington; Malaria Research and Training Center, Bamako, Mali; Harvard School of Public Health (HSPH)CompletedMalaria | Plasmodium Falciparum InfectionMali
-
National Institute of Allergy and Infectious Diseases...National Institutes of Health (NIH); University of Washington; Vaccine Research... and other collaboratorsCompleted
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsUnited States, Puerto Rico, Zimbabwe, South Africa
-
National Institute of Allergy and Infectious Diseases...TerminatedHealthy Adult Immune ResponseUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedMonoclonal Antibody, Human | HIV Antibodies | Neutralizing Antibody | Prevention of HIV InfectionUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsUnited States, South Africa
-
National Institute of Allergy and Infectious Diseases...Advancing Clinical Therapeutics Globally for HIV/AIDS and Other InfectionsCompleted
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infection | Monoclonal Antibody, Human | HIV Antibodies | VRC01 Monoclonal Antibody | Neutralizing AntibodyUnited States
-
National Institute of Allergy and Infectious Diseases...Recruiting
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...RecruitingAcute HIV InfectionUnited States, Brazil, Peru
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...CompletedHIV-1 Infection | HIV Antibodies | Neutralizing Antibody | Viral Load | Monoclonal AntibodyUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...AIDS Clinical Trials GroupCompleted
-
National Institute of Allergy and Infectious Diseases...Centers for Disease Control and Prevention; International AIDS Vaccine Initiative and other collaboratorsWithdrawn
-
National Institute of Allergy and Infectious Diseases...HIV Vaccine Trials NetworkCompleted
-
National Institute of Allergy and Infectious Diseases...Completed
-
University of California, San FranciscoamfAR, The Foundation for AIDS ResearchRecruitingHIV-1-infectionUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsSouth Africa, Zimbabwe, Malawi, Botswana, Kenya, Mozambique, Tanzania
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsUnited States, Peru, Brazil, Switzerland
-
National Institute of Allergy and Infectious Diseases...United States Department of DefenseCompletedHIV InfectionsUganda, Kenya, Tanzania
-
National Institute of Allergy and Infectious Diseases...Terminated
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...HIV Vaccine Trials NetworkCompleted
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...CompletedHealthy Adult Immune Responses to VaccineUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedHealthy Adult Immune Responses to VaccineUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedRNA Virus Infections | Virus Diseases | Flavivirus Infections | Flaviviridae Infections | Zika Virus Infection | Zika Virus | Flaviviral DiseasesUnited States, Puerto Rico, Mexico, Brazil, Colombia, Costa Rica, Ecuador, Panama, Peru
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | HealthyUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...CompletedTrial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy AdultsChikungunya Virus InfectionDominican Republic, Puerto Rico, Guadeloupe, Haiti, Martinique
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | HIV-1 | AIDS VaccinesUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedInnate Immunity | HIV Negative | Adaptive ImmunityUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedEbola Virus Disease | Ebola Vaccines | Marburg Virus Disease | Marburgvirus | EbolavirusUnited States
-
National Institute of Allergy and Infectious Diseases...The Emmes Company, LLC; US Military HIV Research ProgramCompletedHemorrhagic Fever, EbolaUganda
-
National Institute of Allergy and Infectious Diseases...CompletedHealthy Adult Immune Responses to VaccineUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...International AIDS Vaccine InitiativeWithdrawn